"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
| Descriptor ID |
D008175
|
| MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
| Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 2 | 0 | 2 |
| 1998 | 1 | 1 | 2 |
| 1999 | 3 | 2 | 5 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 3 | 0 | 3 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 10 | 4 | 14 |
| 2008 | 8 | 3 | 11 |
| 2009 | 9 | 0 | 9 |
| 2010 | 4 | 0 | 4 |
| 2011 | 9 | 2 | 11 |
| 2012 | 7 | 1 | 8 |
| 2013 | 9 | 3 | 12 |
| 2014 | 9 | 1 | 10 |
| 2015 | 11 | 2 | 13 |
| 2016 | 16 | 0 | 16 |
| 2017 | 15 | 0 | 15 |
| 2018 | 2 | 0 | 2 |
| 2019 | 6 | 1 | 7 |
| 2020 | 11 | 1 | 12 |
| 2021 | 6 | 0 | 6 |
| 2022 | 14 | 1 | 15 |
| 2023 | 8 | 0 | 8 |
| 2024 | 6 | 0 | 6 |
| 2025 | 14 | 0 | 14 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Use of cell-free DNA in early detection of lung cancer: a proof-of concept study. BMC Cancer. 2026 Feb 25; 26(1).
-
Utilization of extended-interval, fixed-dosing of durvalumab, every 4?weeks, in U.S. patients with unresectable stage III NSCLC following concurrent chemoradiation. Future Oncol. 2026 Jan; 22(1):115-121.
-
Examining trends in lung cancer screening over 10?years: Eligibility, participation, cancer detection, and quality implications. Cancer. 2025 Dec 15; 131(24):e70211.
-
Radiation Dose Associated With CT in the Watch the Spot Trial: A Pragmatic Trial of Less Versus More Intensive Strategies for Active Follow-Up of Patients With Small Pulmonary Nodules. J Am Coll Radiol. 2025 12; 22(12):1578-1588.
-
Less Versus More Intensive Surveillance of Pulmonary Nodules Detected Incidentally or by Screening: A Survey of Radiologist Beliefs About Guidelines Implemented in the Watch the Spot Trial. J Am Coll Radiol. 2025 12; 22(12):1589-1597.
-
Systemic Challenges to Lung Cancer Screening in the Safety-Net Setting: Care and Informatics Fragmentation. J Am Coll Radiol. 2025 12; 22(12):1598-1604.
-
Antiviral Treatment Reduces Risk of Development of Lung Cancer and Non-Hodgkin Lymphoma in Patients with Chronic Hepatitis C. Cancer Epidemiol Biomarkers Prev. 2025 Nov 03; 34(11):2025-2031.
-
Longitudinal Adherence to Screening for Colorectal, Cervical, and Lung Cancer in a US Consortium. J Gen Intern Med. 2026 05; 41(7):1761-1770.
-
Reduced Muscle Loss in Patients With NSCLC Taking Fibrates: Findings From a Retrospective Observational Study. J Cachexia Sarcopenia Muscle. 2025 Aug; 16(4):e70016.
-
Automatic Abstraction of Computed Tomography Imaging Indication Using Natural Language Processing for Evaluation of Surveillance Patterns in Long-Term Lung Cancer Survivors. JCO Clin Cancer Inform. 2025 Jul; 9:e2400279.